Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India
New Delhi: Serious legal gaps in the Drugs and Cosmetics Act, 1940, combined with acute shortages of manpower and infrastructure, continue to impede the Central Drugs Standard Control Organisation (CDSCO)…
Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act
Patna: In a significant ruling that could have far-reaching implications for NDPS drug-related prosecutions involving common pharmaceutical compounds, the Patna High Court has held that Phenothiazine and Promethazine do not…
COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients
Washington: A new study has revealed a previously unknown interaction between two cornerstone Parkinson’s disease medications that could unintentionally reduce treatment effectiveness in some patients. Researchers at Yale School of…
Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested
New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…
FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development
Washington: On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…
%20In%20Drug%20Development){kind=link}
IPC releases draft NFI-2026 to promote rational use of medicines
Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…
Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery
Bharat Mandapam witnessed Spectacle of Crazy Innovations by Maker of Ssi Mantra, Best in class Surgical Robot New Delhi: It was a veritable display of innovative potential and prowess of…
US market to dent India pharma earnings even as domestic growth remains firm
New Delhi: India’s pharmaceutical sector is likely to witness steady domestic growth but continued pressure in the US market in the fourth quarter of FY26, according to a report by…
Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg
Biocon Pharma, a subsidiary of Biocon, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Dapagliflozin Tablets, 5 mg and 10 mg. The…
Healthcare, pharma sector to create 2-2.5 million new jobs by 2030
Mumbai, India’s healthcare and pharmaceutical sector is set to enter a capability-led growth phase, potentially creating 2 to 2.5 million new jobs by 2030, while 30 to 35 per cent…
